Literature DB >> 8789410

Uniform characterization of potentiation in simple and complex situations when agents bind to different molecular sites.

G Pöch1, R J Reiffenstein, P Köck, S N Pancheva.   

Abstract

There is general agreement about potentiation in dose-response studies, characterized by a left shift of the dose-response curve of A by a fixed dose of B when B is causing no effect by itself (simple situation). When B causes an effect similar to A (complex situation) by binding to different molecular sites, we propose an analogous analysis. This approach is based on comparison of experimental effects of A and B in combination with theoretical, independent effects, representing an effect of A that is not affected by B. We argue here that comparison of experimental effects with those of dose-additive (additive) combinations is inappropriate. Theoretical considerations and several practical examples show that the magnitude of effects due to additive combinations widely varies with the slope of dose-response curves of A. Consequently, it is also shown that one and the same theoretical effect may appear overadditive, additive, or underadditive. These situations are demonstrated by the experimental examples: inhibition of cytopathic effects in virus-infected cells, loss of righting reflex in mice, and smooth muscle relaxant effects of organic solvents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789410     DOI: 10.1139/y95-217

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Independent action between DvSnf7 RNA and Cry3Bb1 protein in southern corn rootworm, Diabrotica undecimpunctata howardi and Colorado potato beetle, Leptinotarsa decemlineata.

Authors:  Steven L Levine; Jianguo Tan; Geoffrey M Mueller; Pamela M Bachman; Peter D Jensen; Joshua P Uffman
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

2.  Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.

Authors:  Louise A Knight; Christian M Kurbacher; Sharon Glaysher; Augusta Fernando; Ralf Reichelt; Susanne Dexel; Uwe Reinhold; Ian A Cree
Journal:  BMC Cancer       Date:  2009-01-28       Impact factor: 4.430

3.  Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.

Authors:  P A Whitehouse; S J Mercer; L A Knight; F Di Nicolantonio; A O'Callaghan; I A Cree
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.